TP53 gene mutations and protein accumulation in primary vaginal carcinomas.

[1]  R Montesano,et al.  Database of p53 gene somatic mutations in human tumors and cell lines. , 1994, Nucleic acids research.

[2]  D. Lane,et al.  The regulation of p53 function: Steiner award lecture , 1994, International journal of cancer.

[3]  R. Mirimanoff,et al.  Clinical implications of the p53 tumor-suppressor gene. , 1994, The New England journal of medicine.

[4]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[5]  G. Viale,et al.  p53 accumulation in ovarian carcinomas and its prognostic implications. , 1993, Human pathology.

[6]  H. Fox,et al.  Patterns of immunohistochemical staining for proliferating cell nuclear antigen and p53 in benign and neoplastic human endometrium , 1993, Histopathology.

[7]  J. Nesland,et al.  Genetic alterations of the TP53 gene, p53 protein expression and hpv infection in primary cervical carcinomas , 1993, The Journal of pathology.

[8]  R. Bast,et al.  Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer. , 1993, Journal of the National Cancer Institute.

[9]  P. Humphrey,et al.  Mutation of the p53 tumor-suppressor gene is not a feature of endometrial hyperplasias. , 1993, American journal of obstetrics and gynecology.

[10]  K. Heimdal,et al.  Prognostic significance of TP53 alterations in breast carcinoma. , 1993, British Journal of Cancer.

[11]  M. Fritsche,et al.  Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. , 1993, Oncogene.

[12]  J. Nesland,et al.  Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteri , 1993, The Journal of pathology.

[13]  S. N. Agoff,et al.  Regulation of the human hsp70 promoter by p53. , 1993, Science.

[14]  G. Zambetti,et al.  Wild-type p53 binds to the TATA-binding protein and represses transcription. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[15]  B. Vogelstein,et al.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.

[16]  L. Edelmann,et al.  p53 expression in neoplasms of the uterine corpus. , 1992, American journal of clinical pathology.

[17]  A. Levine,et al.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.

[18]  A. Børresen,et al.  Papillomaviruses, p53, and cervical cancer , 1992, The Lancet.

[19]  W. Mason,et al.  Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours , 1992, The Lancet.

[20]  S. Friend,et al.  Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[21]  K. Münger,et al.  The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A. Levine,et al.  The p53 tumour suppressor gene , 1991, Nature.

[23]  C. Mies,et al.  Extraction of DNA from paraffin blocks for Southern blot analysis. , 1991, The American journal of surgical pathology.

[24]  A. Brøgger,et al.  Constant denaturant gel electrophoresis, a modification of denaturing gradient gel electrophoresis, in mutation detection. , 1991, Mutation research.

[25]  H. Ikenberg,et al.  Human Papillomavirus DNA in Invasive Carcinoma of the Vagina , 1990, Obstetrics and gynecology.

[26]  F. Collins,et al.  Mutations in the p53 gene occur in diverse human tumour types , 1989, Nature.

[27]  M. Uhlén,et al.  Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. , 1989, Nucleic acids research.

[28]  A. Levine,et al.  Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life , 1988, Molecular and cellular biology.

[29]  S. Hsu,et al.  A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. , 1981, American journal of clinical pathology.

[30]  D. Lane,et al.  T antigen is bound to a host protein in SY40-transformed cells , 1979, Nature.

[31]  A. Schultz,et al.  Primary Invasive Squamous Carcinoma of the Vagina , 1979, Obstetrics and gynecology.

[32]  James H. Ware,et al.  On distribution-free tests for equality of survival distributions , 1977 .

[33]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .